Financial Services » Investing & Securities | Cellular Biomedicine Group Inc.

Cellular Biomedicine Group Inc. | Cash Flow

Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
13,797.00
15,474.60
19,447.70
28,208.40
25,490.30
38,945.50
Depreciation, Depletion & Amortization
841.20
1,190.50
2,094.60
2,635.00
2,986.00
5,049.50
Other Funds
-
31.70
-
-
-
7,655.20
Funds from Operations
7,670.10
8,953.20
9,852.60
15,612.30
17,158.80
26,240.80
Changes in Working Capital
785.30
1,346.70
1,898.50
255.40
1,434.60
1,127.80
Net Operating Cash Flow
8,455.40
10,299.90
11,751.10
15,867.70
18,593.40
25,113
Capital Expenditures
153.00
320.60
6,135.00
2,733.40
10,192.90
Purchase/Sale of Investments
-
-
1.50
-
-
Net Investing Cash Flow
153.00
1,806.20
7,702.10
2,733.40
10,192.90
Issuance/Reduction of Debt, Net
35.40
-
-
-
-
Net Financing Cash Flow
11,596.80
19,688.60
19,647.20
43,285.60
10,826.50
Net Change in Cash
3,030.30
7,595.40
114.00
24,367.80
17,684.00
Free Cash Flow
8,602.60
-
13,625.60
18,544.60
28,762.50
Deferred Taxes & Investment Tax Credit
76.50
-
-
-
-
-
Net Assets from Acquisitions
-
1,485.50
1,568.60
-
-
Change in Capital Stock
11,561.40
19,720.30
19,647.20
43,285.60
10,826.50
Exchange Rate Effect
42.00
12.80
79.90
316.60
275.80

About Cellular Biomedicine Group

View Profile
Address
1345 Avenue of Americas
New York New York 10105
United States
Employees -
Website http://www.cellbiomedgroup.com
Updated 07/08/2019
Cellular Biomedicine Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development of new treatments for cancerous and degenerative diseases utilizing proprietary cell-based technologies. Its technology includes immune system therapy for treatment of cancer indications and human adipose-derived mesenchymal progenitor cells (haMPC) for treatment of joint and autoimmune diseases The company was founded in 2009 and is headquartered in Cupertino, CA. .

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.